Apotex Inc.,announced that, as of February 13th, 2015, the FDA has accepted for filing the company's application for Filgrastim [Grastofil],...
Sandoz, a Novartis company, announced that the FDA approved Zarxio (filgrastim-sndz) (Zarzio in EU) for all indications included in the...
Sandoz, announced Phase III data that demonstrated similarity of its investigational biosimilar filgrastim compared to the US-licensed reference product, Amgen's...